NOX.AX
Price:
$0.083
Market Cap:
$24.26M
Noxopharm Limited, a drug development company, focuses on developing treatment options for a range of solid tumor cancers and septic shock in Australia and internationally. It primarily develops Veyonda, which is an adjuvant therapy in chemotherapy and radiotherapy for the treatment of late-stage cancers. The company also develops DARRT program that is in Phase 1b/2a for the treatment of metastatic castration-resistant prostate cancer and other solid tumors; LuPIN with combined therapy of Veyonda and 177Lu-PSMA-617 for the treatment of late-stage prostate cancer; IONIC program with Veyonda, which is combined with the Bristol Myers Squibb checkpoint inhibitor Opdivo for the treatment of vario...[Read more]
Industry
Biotechnology
IPO Date
2016-08-09
Stock Exchange
ASX
Ticker
NOX.AX
According to Noxopharm Limited’s latest financial reports and current stock price. The company's current Current Ratio is 3.83. This represents a change of -51.53% compared to the average of 7.89 of the last 4 quarters.
The mean historical Current Ratio of Noxopharm Limited over the last ten years is 8.13. The current 3.83 Current Ratio has changed 4.61% with respect to the historical average. Over the past ten years (40 quarters), NOX.AX's Current Ratio was at its highest in in the December 2016 quarter at 29.24. The Current Ratio was at its lowest in in the January 2016 quarter at 0.
Average
8.13
Median
7.11
Minimum
0.68
Maximum
23.65
Discovering the peaks and valleys of Noxopharm Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 172.79%
Maximum Annual Current Ratio = 23.65
Minimum Annual Increase = -94.61%
Minimum Annual Current Ratio = 0.68
Year | Current Ratio | Change |
---|---|---|
2024 | 3.83 | -59.81% |
2023 | 9.52 | 4.22% |
2022 | 9.13 | 88.56% |
2021 | 4.84 | 162.67% |
2020 | 1.84 | 172.79% |
2019 | 0.68 | -94.61% |
2018 | 12.55 | 76.44% |
2017 | 7.11 | -69.94% |
The current Current Ratio of Noxopharm Limited (NOX.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.49
5-year avg
5.83
10-year avg
8.13
Noxopharm Limited’s Current Ratio is less than Orthocell Limited (4.34), less than Antisense Therapeutics Limited (0), less than Race Oncology Limited (9.32), less than Prescient Therapeutics Limited (8.08), greater than Recce Pharmaceuticals Ltd (0.34),
Company | Current Ratio | Market cap |
---|---|---|
4.34 | $340.38M | |
0 | $52.29M | |
9.32 | $222.35M | |
8.08 | $38.66M | |
0.34 | $110.14M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Noxopharm Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Noxopharm Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Noxopharm Limited's Current Ratio?
How is the Current Ratio calculated for Noxopharm Limited (NOX.AX)?
What is the highest Current Ratio for Noxopharm Limited (NOX.AX)?
What is the 3-year average Current Ratio for Noxopharm Limited (NOX.AX)?
What is the 5-year average Current Ratio for Noxopharm Limited (NOX.AX)?
How does the current Current Ratio for Noxopharm Limited (NOX.AX) compare to its historical average?